This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Cantor Fitzgerald analyst Steve Seedhouse has initiated coverage on Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) with an Overweight rating and set a price target of $8. The company's shares closed at $1.80 on Friday, indicating significant upside potential according to the analyst. This initiation is part of a broader trend where analysts are adjusting their ratings on various companies.